V. Sigurdardottir

Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial

Bert Andersson, Finn Gustafsson, Hans Eiskjær et al. · American Journal of Transplantation · 2014 · 151 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study)

V. Sigurdardottir, Björn Fagerberg, J. Hulthe · Journal of Internal Medicine · 2002 · 145 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +15

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Inger Johansson, Rune Andersson, Vanda Friman et al. · BMC Infectious Diseases · 2015 · 72 citations · Full text

Medicine, Cardiology, Infectious Diseases +17

Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate

Satish Arora, V. Sigurdardottir, Svend Aage Mortensen et al. · The Journal of Heart and Lung Transplantation · 2012 · 60 citations

Pharmacy, Nephrology, Pharmacotherapy +17

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial

Satish Arora, Bert Andersson, Finn Gustafsson et al. · American Journal of Transplantation · 2015 · 57 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14